Friday, 16 October 2026European Markets

B&S Group Stock Went Down By Over 18% In The Last 5 Sessions

Loading stream...

(VIANEWS) - Shares of B&S Group (AEX-Index: BSGR.AS) dropped by a staggering 18.8% in 5 sessions from €5 to €4.06 at 19:09 EST on Friday, following the last session's downward trend. AEX-Index is dropping 1.23% to €746.41, after five consecutive sessions in a row of losses.

About B&S Group

B&S Group S.A. distributes consumer goods worldwide. The company operates through six segments: B&S Liquors, B&S Beauty, B&S Personal Care, B&S Food, B&S Health, and B&S Retail. The B&S Liquors segment distributes branded liquors to wholesalers, consumers, and e-commerce platforms. The B&S Beauty segment distributes and sells branded fragrances and cosmetics to wholesalers, consumers, and e-commerce platforms. The B&S Personal Care segment distributes and sells branded personal and home care products primarily to retailers. The B&S Food segment distributes a range of branded food and beverages products to duty-free, remote, retail, and maritime markets. The B&S Health segment distributes and sells branded medical products and equipment to maritime and remote markets, as well as pharmacies and travel clinics. The B&S Retail segment primarily operates retail stores that sells consumer electronics and multi-category assortments at international airports, regional airports, and other away from home locations. It also provides sourcing, warehousing, distribution, digital commerce, marketing, and brand development solutions. The company was incorporated in 2007 and is based in Betzdorf, Luxembourg.

Earnings Per Share

As for profitability, B&S Group has a trailing twelve months EPS of €0.44.

PE Ratio

B&S Group has a trailing twelve months price to earnings ratio of 9.22. Meaning, the purchaser of the share is investing €9.22 for every euro of annual earnings.

Volatility

B&S Group's last week, last month's, and last quarter's current intraday variation average was a negative 5.56%, a negative 0.92%, and a positive 1.66%.

B&S Group's highest amplitude of average volatility was 6.24% (last week), 1.89% (last month), and 1.66% (last quarter).

More news about B&S Group (BSGR.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com